Keyphrases
Postoperative Pain Management
75%
Total Hip Arthroplasty
57%
Randomized Trial
55%
Paracetamol
52%
Placebo
49%
Clinical Analysis
46%
Ropivacaine
46%
Analgesic
44%
Randomized Clinical Trial
42%
Gabapentin
41%
Total Knee Arthroplasty
41%
Systematic Meta-analysis
41%
Morphine Consumption
40%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
39%
Transversus Abdominis Plane Block
38%
Blinded Trial
34%
Risk of Bias
34%
Postoperative Pain
33%
Healthy Volunteers
32%
Serious Adverse Events
27%
Low Risk
26%
Femoral Nerve Block
26%
Procedure Specific
25%
Beneficial Effects
24%
Acute Pain
23%
Analgesic Effect
23%
Morphine
23%
Confidence Interval
23%
Adductor Canal Block
23%
Harmful Effects
22%
Intensive Care Unit
22%
Pain Score
22%
Delirium
20%
Lumbar Disc Surgery
20%
Ketamine
20%
Perineural
20%
Haloperidol
20%
Quadriceps Strength
20%
Placebo Groups
20%
Hip Arthroplasty
19%
Denmark
19%
Randomized Placebo-controlled Trial
17%
Analgesic Treatment
17%
Pain Level
17%
Adverse Events
16%
Analgesic Drugs
15%
Meta-analysis
15%
Randomized Controlled Trial
15%
Medicine and Dentistry
Postoperative Pain
100%
Analgesia
88%
Placebo
60%
Morphine
57%
Nerve Block
52%
Total Hip Arthroplasty
46%
Sequential Analysis
44%
Systematic Review with Meta-Analysis
41%
Nonsteroid Antiinflammatory Agent
39%
Systematic Review
38%
Total Knee Arthroplasty
38%
Adverse Event
37%
Ropivacaine
35%
Femoral Nerve
34%
Randomized Clinical Trial
32%
Paracetamol
32%
Gabapentin
31%
Pain
26%
Ibuprofen
24%
Hip Arthroplasty
24%
Knee Arthroplasty
24%
Volunteer
22%
Randomized Controlled Trial
22%
Transversus Abdominis Plane Block
20%
Dexamethasone
20%
Surgical Technique
17%
Analgesic Activity
17%
Incision
15%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
63%
Paracetamol
54%
Ropivacaine
50%
Morphine
43%
Postoperative Pain
41%
Ibuprofen
38%
Analgesic Agent
34%
Randomized Clinical Trial
32%
Dexamethasone
31%
Non-Steroidal Anti-Inflammatory Drug
31%
Delirium
31%
Adverse Event
27%
Normal Human
27%
Pain
26%
Table Salt
23%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
21%
Dexmedetomidine
21%
Gabapentin
20%
Clinical Trial
15%
